The Relative Strength (RS) Rating for MaxLinear jumped into a new percentile Friday, with an increase from 78 to 83.
IBD's unique rating measures market leadership with a 1 (worst) to 99 (best) score. The grade shows how a stock's price behavior over the last 52 weeks compares to all the other stocks in our database.
History reveals that the best-performing stocks typically have an RS Rating of at least 80 in the early stages of their moves.
Looking For The Best Stocks To Buy And Watch? Start Here
Now is not an ideal time to jump in since it isn't near a proper buy zone, but see if the stock is able to form a chart pattern and break out.
The company reported 0% earnings growth in its most recent report. Sales rose -40%. Keep an eye out for the company's next round of numbers on or around Jan. 29.
MaxLinear holds the No. 21 rank among its peers in the Electronics-Semiconductor Fabless industry group. Broadcom, NVIDIA and SiTime are among the top 5 highly rated stocks within the group.
RELATED:
Chip Stocks To Watch And Semiconductor Industry News
Stocks With Rising Relative Strength Ratings
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
